We are live on !
Find out more
David Shaw D.E. Shaw & Co
AUM
$210B
Turnover
26.1%
1-Year Est. Return
57.28%
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
This Fund
S&P 500
This Quarter Est. Return
+28.4%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$210B
AUM Growth
+$43.9B
(+26%)
Cap. Flow
+$8.31B
Cap. Flow % of AUM
Cap. Flow %
3.95%
Top 10 Holdings %
Top 10 Hldgs %
15.14%
Holding
5,360
New
872
Increased
1,718
Reduced
1,611
Closed
527
Avg Time Held
Equity + Options
2.6
years
Top 10 Avg Time Held
Equity + Options
0.4
years
Top 20 Avg Time Held
Equity + Options
1.2
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4476
Sana Biotechnology
SANA
$710M
| $140K | ﹤0.01% |
40,090
+1,420
| +4% | +$4.58K |
2025 Q4
2 quarters
|
|
4477
Recursion Pharmaceuticals
RXRX
$2.19B
| $139K | ﹤0.01% |
37,914
-8,094
| -18% | -$26.9K |
2025 Q4
2 quarters
|
|
4478
Archer Aviation
ACHR
$3.42B
| $138K | ﹤0.01% |
29,114
-540,498
| -95% | -$3.14M |
2024 Q3
7 quarters
|
|
4479
Kayne Anderson BDC
KBDC
$817M
| $138K | ﹤0.01% |
10,167
-4,522
| -31% | -$65.2K |
2026 Q1
1 quarter
|
|
|
CCIXW
4480
DELISTED
Churchill Capital Corp IX Warrant
CCIXW
| $136K | ﹤0.01% |
175,000
| – | – |
2024 Q3
7 quarters
|
|
4481
AudioEye
AEYE
$157M
| $136K | ﹤0.01% |
23,450
-9,669
| -29% | -$67.3K |
2026 Q1
1 quarter
|
|
4482
LifeMD
LFMD
$114M
| $136K | ﹤0.01% |
+32,924
| New | +$145K |
2026 Q2
0 quarters
|
|
4483
Dakota Gold
DC
$798M
| $135K | ﹤0.01% |
31,754
-39,201
| -55% | -$212K |
2025 Q4
2 quarters
|
|
4484
CALL
Daqo New Energy
DQ
$856M
| $135K | ﹤0.01% |
10,100
-370,000
| -97% | -$6.72M |
2023 Q4
10 quarters
|
|
4485
Vendome Acquisition Corp I Warrant
VNMEW
| $135K | ﹤0.01% |
450,000
| – | – |
2025 Q3
3 quarters
|
|
4486
AH Realty Trust
AHRT
$471M
| $135K | ﹤0.01% |
19,048
+4,997
| +36% | +$32.1K |
2026 Q1
1 quarter
|
|
4487
Critical Metals Corp Warrants
CRMLW
$13.6M
| $135K | ﹤0.01% |
37,500
| – | – |
2025 Q4
2 quarters
|
|
4488
PUT
Conagra Brands
CAG
$7.28B
| $135K | ﹤0.01% |
10,000
-83,900
| -89% | -$1.17M |
2025 Q3
3 quarters
|
|
4489
FG Imperii Acquisition Corp
FGII
$292M
| $135K | ﹤0.01% |
+13,545
| New | +$134K |
2026 Q2
0 quarters
|
|
4490
Mobia Medical
MOBI
$373M
| $134K | ﹤0.01% |
+10,000
| New | +$129K |
2026 Q2
0 quarters
|
|
|
UCFI
4491
CN Healthy Food Tech Group
UCFI
| $131K | ﹤0.01% |
23,807
| – | – |
2025 Q4
2 quarters
|
|
4492
Integra Resources
ITRG
$454M
| $131K | ﹤0.01% |
57,707
-169,683
| -75% | -$458K |
2026 Q1
1 quarter
|
|
4493
Abacus Global Management
ABX
$859M
| $131K | ﹤0.01% |
+12,197
| New | +$111K |
2026 Q2
0 quarters
|
|
|
IPEXR
4494
DELISTED
Inflection Point Acquisition Corp V Rights
IPEXR
| $130K | ﹤0.01% |
200,000
| – | – |
2025 Q1
5 quarters
|
|
4495
Social Commerce Partners Warrant
SCPQW
| $129K | ﹤0.01% |
175,000
| – | – |
2026 Q1
1 quarter
|
|
4496
Medical Properties Trust
MPT
$1.08B
| $128K | ﹤0.01% |
27,718
-55,278
| -67% | -$274K |
2025 Q4
2 quarters
|
|
4497
Eagle Nuclear Energy Corp Warrants
NUCLW
$3.68M
| $127K | ﹤0.01% |
87,883
| – | – |
2026 Q1
1 quarter
|
|
4498
American Coastal Insurance
ACIC
$475M
| $127K | ﹤0.01% |
+11,422
| New | +$126K |
2026 Q2
0 quarters
|
|
4499
Pyrophyte Acquisition Corp II Warrants
PAII.WS
| $125K | ﹤0.01% |
250,000
| – | – |
2025 Q3
3 quarters
|
|
4500
Infinite Eagle Acquisition Corp Rights
IEAGR
| $122K | ﹤0.01% |
625,000
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.